107: Caring for LGBT Persons in Dermatology Flashcards

1
Q

What does the term LGBT encompass?

A

LGBT is an umbrella term that includes MSM (Men who have Sex with Men) and WSW (Women who have Sex with Women) who engage in same-sex sexual behaviors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does sexual orientation relate to sexual behavior?

A

Sexual orientation does not dictate sexual behavior. For example, a self-identified straight person may engage in same-sex sexual behaviors, while a self-identified gay person may not be sexually active.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are MSM and WSW?

A

MSM and WSW are terms that describe same-sex sexual behaviors regardless of self-identified sexual orientation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is the term ‘homosexual’ considered outdated by many in the LGBT community?

A

The term ‘homosexual’ is often viewed as outdated and derogatory by many LGBT persons because it does not encompass the complexity of sexual orientation and identity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What dermatological conditions disproportionately affect MSM?

A

MSM are disproportionately impacted by dermatologically relevant conditions, including HIV, STDs, and other infectious and non-infectious diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the recommendations for HIV and STD screening for MSM?

A

Recommendations for MSM include more frequent screenings for HIV and additional STDs such as syphilis, urethral/rectal/pharyngeal gonorrhea, and Chlamydia. MSM in mutually monogamous relationships might not require more frequent screening.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the HPV vaccination recommendation for MSM?

A

HPV vaccination is indicated for MSM and for women through age 26 years; for non-MSM men, it is indicated through age 21 years (but permissible through age 26 years).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is PrEP and its significance for MSM?

A

PrEP (pre-exposure prophylaxis) is indicated for HIV-negative MSM who are at high risk of acquiring HIV. Daily emtricitabine-tenofovir disoproxil fumarate can reduce HIV incidence in MSM (and transgender women) by up to 92%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is nPEP and when is it indicated for MSM?

A

Nonoccupational HIV post-exposure prophylaxis (nPEP) is indicated in settings of substantial risk exposure to HIV transmission for MSM, such as unprotected receptive anal intercourse with an untreated HIV-positive person. It must begin within 72 hours of exposure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does gender identity refer to?

A

One’s basic internal sense of gender, such as being a man or a woman, which does not dictate sexual orientation or behavior.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the implications of sexual orientation on sexual behavior in the context of LGBT individuals?

A

Sexual orientation does not dictate sexual behavior. For example, a self-identified straight person may engage in same-sex sexual behaviors, while a self-identified gay person may not be sexually active.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the STD risks for women who have sex with women (WSW)?

A

WSW are at risk of acquiring STDs from current and prior female and/or male partners, including genital HPV, herpes simplex virus, syphilis, and HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the seroprevalence of herpes simplex virus Type 2 among women with same-sex partners?

A

30%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Do screening guidelines for STDs differ between WSW and women who do not have sex with women?

A

No, they do not differ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What types of gender-affirming treatments may transgender persons undergo?

A

Transgender persons may undergo psychological counseling, hormone therapy, and surgical interventions such as facial feminizing procedures, ‘top’ surgery, and ‘bottom’ surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What role can dermatologists play in the care of transgender persons undergoing gender-affirming treatments?

A

Dermatologists can manage cutaneous adverse effects of hormonal and surgical treatments, perform safe and effective procedures for gender-affirming physical transformation, and facilitate screening and preventive care.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the potential cutaneous adverse effects of hormone therapy and surgical interventions in transgender persons?

A

Potential cutaneous adverse effects include keloids and other skin changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the importance of contraception counseling for transgender men?

A

Contraception counseling is crucial because transgender men who retain female natal reproductive organs can become pregnant, even while taking testosterone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the desired effects of feminizing hormone therapy in transgender women?

A

Breast development, reduction of body and facial hair, redistribution of subcutaneous fat, change in sweat and odor pattern, arrest or reversal of hair loss, decreased sebum production, improvement in acne vulgaris, and reduction in gender dysphoria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What complications can arise from unlicensed silicone or filler injections in transgender women?

A

Serious complications include foreign-body granulomatous dermatitis, bacterial or atypical mycobacterial infections, bleeding, pain, scarring, ulceration, fistula formation, gross disfiguration, lymphedema, silicone migration or embolism, sepsis, hypersensitivity pneumonitis, and death can occur hours to decades later.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What treatments are available for silicone granulomas in transgender persons?

A

Treatment options include intra-lesional corticosteroid, topical imiquimod or tacrolimus, oral doxycycline or minocycline, isotretinoin, etanercept, carbon dioxide ablative laser, and surgical excision.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What should dermatologists provide to transgender persons regarding injectable treatments?

A

Dermatologists can provide safe, effective gender-affirming injectable treatments, including facial contouring with botulinum toxin neuro-modulation and soft-tissue augmentation to add volume to the cheeks, lips, or chin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is included in culturally competent care for transgender patients?

A

Culturally competent care includes use of inclusive language and demonstration of equality and respect, eliciting relevant information on sex anatomy, gender identity, sexual orientation, and sexual behaviors in an effective and sensitive manner.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Why is it important to screen transgender persons who have received fillers from unlicensed providers?

A

Transgender persons with fillers from unlicensed low-cost ‘pumpers’ should be screened for hepatitis C due to the potential health risks associated with unregulated procedures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What screening and prevention services should transgender persons receive?

A

Transgender persons should receive appropriate HIV and STD screening and prevention services, including vaccination, PrEP, and nPEP, based on their sexual behaviors and the gender(s) of their sex partners.

26
Q

What does the CDC recommend regarding oropharyngeal testing for gonorrhea?

A

The CDC recommends oropharyngeal testing specifically for gonorrhea, although many available tests can screen for both gonorrhea and Chlamydia.

27
Q

Is routine meningococcal vaccination recommended by the CDC for all MSM?

A

No, the CDC does not recommend routine meningococcal vaccination for all MSM; however, some state and local jurisdictions have recommended it in response to outbreaks.

28
Q

What has prompted some state and local jurisdictions to recommend meningococcal vaccination for MSM?

A

Outbreaks of meningococcal disease.

29
Q

What is the association between male pattern alopecia and testosterone treatment in transgender men?

A

33% develop mild alopecia and 31% develop moderate to severe alopecia, with treatment options like minoxidil or finasteride not well studied.

30
Q

Can organs become pregnant while taking testosterone?

A

Yes, organs can become pregnant even while taking testosterone.

31
Q

What complications can arise from unlicensed silicone or filler injections in transgender women?

A

Serious complications include foreign-body granulomatous dermatitis, infections, bleeding, pain, scarring, ulceration, fistula formation, disfiguration, lymphedema, silicone migration or embolism, sepsis, hypersensitivity pneumonitis, and death.

32
Q

What treatments are available for silicone granulomas?

A

Intra-lesional corticosteroid, topical imiquimod or tacrolimus, oral doxycycline or minocycline, isotretinoin, etanercept, carbon dioxide ablative laser, or surgical excision.

33
Q

What should dermatologists provide to transgender persons regarding injectable treatments?

A

Safe, effective gender-affirming injectable treatments, including facial contouring with botulinum toxin neuro-modulation and soft-tissue augmentation.

34
Q

What is the importance of culturally competent care in dermatology for transgender patients?

A

It includes the use of inclusive language, demonstrating equality and respect, and eliciting relevant information on sex anatomy, gender identity, and sexual behaviors in a sensitive manner.

35
Q

What screening and prevention services should transgender persons receive?

A

Appropriate HIV and STD screening and prevention services, including vaccination, PrEP, and nPEP, based on their sexual behaviors and the gender(s) of their sex partners.

36
Q

What are the cutaneous effects of testosterone on transgender men?

A

The cutaneous effects of testosterone on transgender men include increased facial and body hair, redistribution of subcutaneous fat, changes in sweat and odor patterns, and acne. Acne develops in 88% to 94% of transgender men within 4 to 6 months of initiation, with severity decreasing after 12 months.

37
Q

How can severe acne be managed in transgender men undergoing testosterone therapy?

A

Management of severe testosterone-induced acne may involve topical acne treatments and/or oral antibiotics without needing to adjust hormone therapy, or isotretinoin treatment for severe cases.

38
Q

What considerations should be made regarding contraception counseling for transgender men?

A

Contraception counseling is crucial for transgender men who retain female natal reproductive organs, as they can become pregnant even while taking testosterone.

39
Q

What are the desired effects of feminizing hormone therapy in transgender women?

A

The desired effects of feminizing hormone therapy in transgender women include breast development, reduction of body and facial hair, redistribution of subcutaneous fat, change in sweat and odor patterns, arrest or reversal of hair loss, decreased sebum production, improvement in acne vulgaris, and reduction in gender dysphoria.

40
Q

What are the serious complications associated with unlicensed silicone or filler injections in transgender women?

A

Serious complications from unlicensed silicone or filler injections in transgender women can include foreign-body granulomatous dermatitis, bacterial or atypical mycobacterial infections, bleeding, pain, scarring, ulceration, fistula formation, gross disfiguration, lymphedema, silicone migration or embolism, sepsis, hypersensitivity pneumonitis, and even death.

41
Q

What approaches should dermatologists take to provide culturally competent care for transgender patients?

A

Dermatologists should provide culturally competent care by using inclusive language, demonstrating equality and respect, and eliciting relevant information on sex anatomy, gender identity, sexual orientation, and sexual behaviors in an effective and sensitive manner.

42
Q

What treatment options are available for severe acne in transgender men?

A

Severe testosterone-induced acne can be treated with topical acne treatments, oral antibiotics, or isotretinoin. Hormone therapy does not need to be adjusted.

43
Q

What are the recommended treatments for persistent facial hair growth in transgender women?

A

Recommended treatments include topical eflornithine, electrolysis, photoepilation, or laser treatments.

44
Q

What are the potential treatments for moderate alopecia in transgender men?

A

Potential treatments include minoxidil or finasteride, but their effectiveness for testosterone-induced alopecia in transgender men has not been well studied. Hair transplantation may be considered for severe cases.

45
Q

What are the treatment options for a transgender woman with granulomatous dermatitis after silicone injections?

A

Treatment options for silicone granuloma include intralesional corticosteroids, topical imiquimod or tacrolimus, oral doxycycline or minocycline, isotretinoin, etanercept, carbon dioxide ablative laser, or surgical excision.

46
Q

What counseling should be provided to a transgender man wishing to avoid pregnancy while on testosterone therapy?

A

Contraception counseling is important because transgender men who retain female natal reproductive organs can become pregnant even while taking testosterone.

47
Q

What noninvasive gender-affirming treatments can a dermatologist provide to a transgender woman?

A

Dermatologists can provide facial contouring with botulinum toxin neuromodulation and soft-tissue augmentation to add volume to the cheeks, lips, or chin.

48
Q

What changes in sweat and odor patterns can occur after starting testosterone therapy?

A

Yes, changes in sweat and odor patterns are common. Other cutaneous effects include increased facial and body hair, redistribution of subcutaneous fat, and acne.

49
Q

What preventive measures should be recommended for a transgender woman concerned about HIV and STDs?

A

Preventive measures include appropriate HIV and STD screening, vaccination, PrEP, and nPEP based on sexual behaviors and the gender(s) of their sex partners.

50
Q

What are the desired effects of feminizing hormone therapy in transgender women?

A

Desired effects include breast development, reduction of body and facial hair, redistribution of subcutaneous fat, changes in sweat and odor patterns, arrest or reversal of hair loss, decreased sebum production, improvement in acne vulgaris, and reduction in gender dysphoria.

51
Q

What is the expected timeline for acne severity in transgender men after starting testosterone therapy?

A

Acne develops in 88% to 94% of transgender men within 4 to 6 months of starting testosterone therapy. Severity typically decreases after 12 months. Management includes topical acne treatments or oral antibiotics.

52
Q

What serious complications should be considered for a transgender woman who has received low-cost filler injections?

A

Serious complications include foreign-body granulomatous dermatitis, bacterial or atypical mycobacterial infections, bleeding, pain, scarring, ulceration, fistula formation, gross disfiguration, lymphedema, silicone migration or embolism, sepsis, hypersensitivity pneumonitis, and death.

53
Q

What is the most aggressive treatment option for severe testosterone-induced acne?

A

The most aggressive treatment option for severe testosterone-induced acne is isotretinoin.

54
Q

What procedures are commonly performed for facial feminization in transgender women?

A

Common procedures include facial feminization and body contouring.

55
Q

What is the prevalence of alopecia in transgender men undergoing testosterone therapy?

A

Mild alopecia develops in 33% of transgender men, and moderate to severe alopecia develops in 31%. Treatments include minoxidil or finasteride, though their effectiveness is not well studied. Hair transplantation may be considered for severe cases.

56
Q

What medications are typically used in feminizing hormone therapy?

A

Feminizing hormone therapy typically includes estrogens and antiandrogens such as medroxyprogesterone acetate, oral progesterone, spironolactone, finasteride, and dutasteride.

57
Q

Should hormone therapy be discontinued for a transgender man experiencing acne?

A

No, hormone therapy does not need to be discontinued. Acne can be managed with topical treatments, oral antibiotics, or isotretinoin for severe cases.

58
Q

What additional treatments can be recommended for facial hair resistance to hormonal therapy in transgender women?

A

Additional treatments include topical eflornithine, electrolysis, photoepilation, or laser treatments.

59
Q

What advice should be provided to a transgender man concerned about pregnancy while on testosterone therapy?

A

Transgender men who retain female natal reproductive organs can become pregnant even while taking testosterone. Contraception counseling is essential.

60
Q

What screening should be performed for a transgender woman who has received unlicensed silicone injections?

A

Screening for hepatitis C should be performed in transgender persons who have received fillers from unlicensed providers.

61
Q

What practices should be followed for culturally competent care of transgender patients?

A

Culturally competent care includes using inclusive language, demonstrating equality and respect, and eliciting relevant information on sex anatomy, gender identity, sexual orientation, and sexual behaviors in an effective and sensitive manner.

62
Q

How does feminizing hormone therapy affect acne vulgaris in transgender women?

A

Feminizing hormone therapy decreases sebum production and improves acne vulgaris.